Calpain II Activators

Calpain Inhibitor II, a proteolytic enzyme, has several inhibitors that modulate its activity, thereby regulating cellular protein integrity and function. Compounds like ALLN (N-Acetyl-Leu-Leu-Norleucinal) and Calpeptin specifically bind to the active site of Calpain Inhibitor II, hindering its ability to cleave substrates. This inhibition is crucial for preserving the structural and functional integrity of cellular proteins. Similarly, MDL 28170 (Val-Leu-Lys acid) and PD150606 selectively target Calpain Inhibitor II, with MDL 28170 directly blocking the catalytic activity and PD150606 binding to the calcium-binding domain, thus preventing enzyme activation.

Additional inhibitors, such as Leupeptin, E-64, and AK295, function by reversibly or irreversibly binding to the active site of Calpain Inhibitor II, impeding its proteolytic activity. These inhibitors play a significant role in protecting cellular proteins, especially during conditions of cellular stress or pathology where calpain activity might be detrimental. Synthetic inhibitors like SJA6017, A-705253, and SNJ-1945 have been developed to target Calpain Inhibitor II effectively, offering strategies to mitigate calpain-mediated cellular damage. CI-2 (Calpain Inhibitor 2) and Z-Leu-Leu-Leu-CHO (MG-132) further contribute to this regulation by preventing the interaction of Calpain Inhibitor II with its substrates, thereby reducing unwanted proteolysis. Collectively, these inhibitors are crucial in regulating the activity of Calpain Inhibitor II, ensuring balanced proteolysis and maintaining cellular homeostasis.